The European Chemicals Agency (ECHA) has announced its selection of approximately 200 substances, which have been registered by 800 companies in approximately 1,300 registration dossiers, for further scrutiny by the member state competent authorities. These competent authorities will conduct a manual examination of the dossiers to determine if there is a need for regulatory action, which includes compliance check, substance evaluation, harmonized classification and labeling, authorization or restriction.
The ECHA selection is been based on an automated screening, with emphasis on substances that are potentially carcinogenic, mutagenic or toxic to reproduction (CMR), persistent bioaccumulative toxic (PBT), endocrine disrupting or sensitizing. They are then filtered based on uses that could lead to potential exposure to humans or released to the environment.
The agency has also announced the availability of the new version of the Registry for Biocidal Products (R4BP 3.3). This will allow the following:
- Removal of limitation regarding the authorization holder for same biocidal product authorizations
- Improvement of the Summary of Product Characteristics (SPC) handling
- Improvement of the transfer of simplified authorizations
- Use of BPR Annex I active substance assets to begin new product authorization applications
- More user-friendly features such as international keyboard support for usernames and more specific error messages